Global Patent Index - EP 1389044 A4

EP 1389044 A4 20060705 - PPAR-ALPHA-GAMMA LIGANDS OR AGONISTS FOR THE TREATMENT OF INFLAMMATION

Title (en)

PPAR-ALPHA-GAMMA LIGANDS OR AGONISTS FOR THE TREATMENT OF INFLAMMATION

Title (de)

PPAR-ALPHA-GAMMA-LIGANDEN ODER -AGONISTEN FÜR DIE BEHANDLUNG VON ENTZÜNDUNGEN

Title (fr)

AGONISTES OU LIGANDS PPAR-ALPHA-GAMMA DESTINES AU TRAITEMENT D'INFLAMMATIONS

Publication

EP 1389044 A4 20060705 (EN)

Application

EP 02731386 A 20020412

Priority

  • US 0211990 W 20020412
  • US 28474701 P 20010418

Abstract (en)

[origin: WO02085123A1] The invention encompasses a method for treating or preventing an inflammatory disease or condition in a mammalian patient in need of such treatment or prevention comprising administering to said patient a compound that is capable of simultaneously binding PPAR alpha and PPAR gamma or concomitantly administering a compound that selectively binds PPAR alpha with a compound that selectively binds PPAR gamma in an amount that is effective to treat or prevent the inflammatory disease or condition. The invention also encompasses a method for treating or preventing an inflammatory disease or condition in a mammalian patient in need of such treatment or prevention comprising administering to said patient a compound that is capable of simultaneously binding and activating PPAR alpha and PPAR gamma or concomitantly administering a compound that selectively binds and activates PPAR alpha with a compound that selectively binds and activates PPAR gamma in an amount that is effective to treat or prevent the inflammatory disease or condition.

IPC 1-7

A01N 61/00; A01N 37/18; A61K 31/00; A61K 38/00

IPC 8 full level

A61K 45/00 (2006.01); A61K 31/00 (2006.01); A61K 38/17 (2006.01); A61K 45/06 (2006.01); A61P 1/00 (2006.01); A61P 17/06 (2006.01); A61P 19/00 (2006.01); A61P 19/06 (2006.01); A61P 29/00 (2006.01)

CPC (source: EP)

A61K 31/00 (2013.01); A61K 45/06 (2013.01); A61P 1/00 (2017.12); A61P 17/06 (2017.12); A61P 19/00 (2017.12); A61P 19/06 (2017.12); A61P 29/00 (2017.12); A61P 37/00 (2017.12)

C-Set (source: EP)

A61K 31/00 + A61K 2300/00

Citation (search report)

  • [X] WO 0125226 A1 20010412 - BETHESDA PHARMACEUTICALS INC [US], et al
  • [A] US 6200998 B1 20010313 - SAHOO SOUMYA P [US], et al
  • [A] RICOTE M ET AL: "THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-A IS A NEGATIVE REGULATOR OF MACROPHAGE ACTIVATION", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 391, no. 6662, January 1998 (1998-01-01), pages 79 - 82, XP000906976, ISSN: 0028-0836
  • See references of WO 02085123A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 02085123 A1 20021031; CA 2443935 A1 20021031; EP 1389044 A1 20040218; EP 1389044 A4 20060705; JP 2004528329 A 20040916

DOCDB simple family (application)

US 0211990 W 20020412; CA 2443935 A 20020412; EP 02731386 A 20020412; JP 2002582715 A 20020412